SGLT2 inhibitors in CKD and HFpEF: two new large trials and two new meta-analyses

Br J Cardiol. 2023 Feb 21;30(1):3. doi: 10.5837/bjc.2023.003. eCollection 2023.
No abstract available

Keywords: cardiovascular disease; chronic kidney disease; heart failure; sodium-glucose co-transporter 2 (SGLT2) inhibitor.

Publication types

  • Editorial